Jinming Yu

机构：Shandong First Medical University · ORCID：0000-0002-4618-2490

发表论文 22 篇 · 总被引 222 次 · h-index 8

代表论文

• Potential immune escape mechanisms underlying the distinct clinical outcome of immune checkpoint blockades in small cell lung cancer (2019 · Journal of Hematology & Oncology · 被引 106)
• End-of-life chemotherapy is associated with poor survival and aggressive care in patients with small cell lung cancer (2018 · Journal of Cancer Research and Clinical Oncology · 被引 22)
• Incorporation of circulating tumor cells and whole-body metabolic tumor volume of 18F-FDG PET/CT improves prediction of outcome in IIIB stage small-cell lung cancer (2018 · Chinese Journal of Cancer Research · 被引 20)
• Rationale and Design of the Phase 3 KEYLYNK-013 Study of Pembrolizumab With Concurrent Chemoradiotherapy Followed by Pembrolizumab With or Without Olaparib for Limited-Stage Small-Cell Lung Cancer (2022 · Clinical Lung Cancer · 被引 16)
• Association of Twice-Daily Radiotherapy With Subsequent Brain Metastases in Adults With Small Cell Lung Cancer (2019 · JAMA Network Open · 被引 13)
• Exploring the value of FAP-targeted PET/CT in differentiating breast cancer molecular subtypes: a preliminary study (2024 · European Journal of Nuclear Medicine and Molecular Imaging · 被引 12)